Eldelumab
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Human |
| Target | interferon gamma-induced protein |
| Clinical data | |
| ATC code | none |
| Identifiers | |
| CAS Number | 946414-98-8 |
| ChemSpider | none |
| Chemical and physical data | |
| Formula | C6502H10024N1736O2026S48 |
| Molar mass | 146.5 kg/mol |
Eldelumab is a monoclonal antibody designed for the treatment of Crohn's disease and ulcerative colitis.[1]
This drug was developed by Bristol-Myers Squibb.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Eldelumab, American Medical Association.
This article is issued from Wikipedia - version of the 6/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.